Market Insights Health OTC Pharmaceuticals

Eye Care - Japan

Japan

In Japan, the revenue generated in the Eye Care market market in 2024 amounts to ¥€0.89bn.
It is projected that the market will experience an annual growth rate of 3.16% (CAGR 2024-2029).
When compared to other countries globally, the in the United States leads with a revenue of €1,165.00m in 2024.
On a per person basis, the revenue generated in Japan amounts to ¥€7.24 per person in 2024.
Japan's eye care market is driven by a strong cultural emphasis on maintaining healthy vision through traditional remedies and preventive measures.

Key regions: Europe, Australia, Brazil, China, United States

Marché

Région

Comparaison de régions

Monnaie

Analyst Opinion

The Eye Care market in Japan is experiencing significant growth due to changing customer preferences, emerging trends, and local special circumstances. Customer preferences in the Eye Care market in Japan have shifted towards a greater emphasis on preventive measures and overall eye health. With an aging population and increasing awareness about the importance of eye care, consumers are seeking products that can help maintain good vision and prevent eye-related problems. This has led to a rise in demand for products such as eye drops, vitamins, and supplements that promote eye health. Additionally, there is a growing interest in natural and organic eye care products, as consumers become more conscious about the ingredients they put in and around their eyes.Trends in the market indicate a strong focus on innovation and technological advancements. Japan is known for its cutting-edge technology and this is reflected in the Eye Care market as well. Companies are investing in research and development to introduce new and improved products that cater to the specific needs of consumers. For example, there has been a surge in the development of contact lenses with advanced features such as UV protection and moisture retention. Furthermore, wearable technology for eye care, such as smart glasses and eye-tracking devices, is gaining popularity among tech-savvy consumers.Local special circumstances in Japan also contribute to the growth of the Eye Care market. The country has a high prevalence of myopia, or nearsightedness, among its population. This has created a demand for corrective measures such as eyeglasses and contact lenses. Additionally, the Japanese work culture, which often involves long hours in front of screens, has led to an increase in eye strain and related issues. As a result, products that alleviate eye fatigue and provide relief from digital eye strain are in high demand.Underlying macroeconomic factors further support the growth of the Eye Care market in Japan. The country has a stable economy and a high standard of living, allowing consumers to allocate a significant portion of their budget towards healthcare and wellness products. Furthermore, the government's focus on promoting healthcare and preventive measures has created a favorable environment for the Eye Care market to thrive. This includes initiatives to raise awareness about eye health and provide access to affordable eye care services.In conclusion, the Eye Care market in Japan is experiencing growth driven by customer preferences for preventive measures and overall eye health, emerging trends in innovation and technology, local special circumstances such as high prevalence of myopia and eye strain, and underlying macroeconomic factors that support the healthcare sector. As consumers continue to prioritize eye care, the market is likely to witness further expansion in the coming years.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.